Home Tools
Log in
Cart

Search Result

Search Results for " cholangiocarcinoma "

11

Compounds

Cat No. Product Name Synonyms Targets
T12401 Pemigatinib INCB054828 FGFR
Pemigatinib (INCB054828) is an orally active, selective inhibitor of FGFR(IC50s of 0.4 nM, 0.5 nM, 1.2 nM, 30 nM for FGFR1, FGFR2, FGFR3, FGFR4, respectively).
T3878 Raddeanin A NSC382873,Anemodeanin A,Raddeanin R3 Apoptosis , HDAC
Raddeanin A (NSC-382873) has moderate inhibitory activity against histone deacetylases (HDACs). Raddeanin A has high antiangiogenic potency, antitumor activity.
TN4591 Murralongin Others
Murralongin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100.
TN4564 Micromelin Others
Micromelin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100.
T70143 Derazantinib dihydrochloride
Derazantinib is a multi-kinase inhibitor with pan-FGFR activity which has shown preliminary therapeutic activity against FGFR2 fusion-positive intrahepatic cholangiocarcinoma (iCCA). Derazantinib dihydrochloride is a sa...
TN4570 Minumicrolin Others
Minumicrolin is a plant growth inhibitor against the 2nd leaf sheath elongation of rice seedlings. Murrangatin exhibits cytotoxicity against cholangiocarcinoma cell line, KKU-100, it might be valuable anti-tumor-promotin...
T72932 Triphen diol
Triphen Diol, a phenol diol derivative, exhibits potent anticancer properties against pancreatic cancer and cholangiocarcinoma, efficiently inducing pancreatic cell apoptosis via both caspase-mediated and caspase-indepen...
TN4592 Murrangatin IL Receptor , TNF , COX , Prostaglandin Receptor
Murrangatin may be a valuable anti-tumor-promoting agent, it can significantly inhibit Epstein-Barr virus early antigen (EBV-EA) activation, and preserve the high viability of Raji cells, it also exhibits cytotoxicity ag...
T71002 Infigratinib acetate
Infigratinib acetate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities.
T71004 Infigratinib monohydrate
Infigratinib monohydrate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities.
T71003 Infigratinib mesylate
Infigratinib mesylate (BGJ398) is an orally bioavailable pan inhibitor of human FGFR with potential antiangiogenic and antineoplastic activities.
TargetMol